✦ LIBER ✦

32P as an Adjunct to Standard Therapy for Locally Advanced Unresectable Pancreatic Cancer: A Randomized Trial

✍ Scribed by Alexander Rosemurgy; German Luzardo; Jennifer Cooper; Carl Bowers; Emmanuel Zervos; Mark Bloomston; Sam Al-Saadi; Robert Carroll; Hemant Chheda; Larry Carey; Steven Goldin; Shane Grundy; Bruce Kudryk; Bruce Zwiebel; Thomas Black; John Briggs; Paul Chervenick

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 185 KB
Volume: 12
Category: Article
ISSN: 1091-255X
DOI: 10.1007/s11605-007-0430-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab plus gemcitabine and oxalipl

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

Interim results of a randomized trial of

Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix

✍ Kenneth B. Roberts; Nelson Urdaneta; Raul Vera; Andres Vera; Enrique Gutierrez; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 380 KB 👁 3 views

The purpose of this study was to determine the efficacy of mitomycin C as an adjunct to radiotherapy for the treatment of locally advanced cervix cancer. Patients with squamous-cell carcinoma of the cervix, stages IB2-IVA, were randomized to receive radiotherapy alone or radiotherapy with concomitan